Re:Lung cancer pill cuts risk of death by half
by haldujai on Sunday June 04, 2023 @11:29AM
(#36186377)
Very sober given the costs and %age of patients who didn’t receive adjuvant chemo in the initial trial.
Interested to see their detailed results but I’m mildly suspicious this will be AstraZeneca PR buffing underwhelming results.
The headline here is really strong -- and the actual abstract is much more sober: "5-year OS rate was 88% with osimertinib vs 78% with placebo" [Full abstract is here: https://meetings.asco.org/abstracts-presentations/219805 ]
P.S. Hi Chris! (I think I picked up a summer student from you last week!)